Additional Information

Description

Metoprolol Tartrate Injection, provided by Pfizer Inc / Consumer Healthcare, offers a potent treatment option for definite or suspected acute myocardial infarction. It is indicated for use in hemodynamically stable patients to reduce cardiovascular mortality when combined with oral metoprolol maintenance therapy.

Each injection contains 5 mg of metoprolol tartrate in a 5 mL single-dose glass flip-top vial. Metoprolol tartrate Injection, USP, is a selective beta1-adrenoreceptor blocking agent, designed for intravenous administration. This formulation targets specific receptors, aiding in the management of cardiac conditions.

Packaged in boxes containing 10 vials, this product ensures convenient access and administration in clinical settings.Metoprolol Tartrate Injection plays a crucial role in the comprehensive treatment of acute myocardial infarction, providing physicians with a reliable tool to improve patient outcomes and reduce cardiovascular mortality when used in accordance with established therapeutic protocols.